News in the classification of WHO 2022 bladder tumors
- PMID: 36704871
- PMCID: PMC10342216
- DOI: 10.32074/1591-951X-838
News in the classification of WHO 2022 bladder tumors
Abstract
The fifth-edition of World Health Organization (WHO) Classification of Tumors series for urinary and male genital tract tumors has been published, six years later the fourth-edition. In these years, new treatment approaches have been implemented and new molecular data on urological cancers are known.
Morphology remains the groundwork for taxonomy of the urinary tract tumors. However, a molecular approach to classification of urothelial carcinomas and the management of selected neoplasms with new therapeutic modalities such as immunotherapy are emerging. More data are needed for the application of these advances in routine pathology practice and patient management.
The 2022 World Health Organization (WHO) Classification of Tumors of the Urinary System and Male Genital Organs represents an update in classification on urinary tract tumors. It also offers new insights with regards to the grading of heterogeneous non-invasive urothelial neoplasms, the definition of inverted neoplasms, the grading of invasive urothelial carcinomas, the diversity of morphological appearance of urothelial carcinomas, the definition of precursor lesions and the lineage of differentiation of the tumors.
Keywords: WHO 2022; bladder; grading; molecular subgroups; urothelial tumors.
Copyright © 2023 Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology.
Conflict of interest statement
The authors declare no conflict of interest.
MRR, EMC, TT and GJN served as expert members in 2022 WHO Classification of Tumours Editorial Board. Urinary and male genital tumours.
Figures












Similar articles
-
Histologic grading of urothelial carcinoma: a reappraisal.Hum Pathol. 2012 Dec;43(12):2097-108. doi: 10.1016/j.humpath.2012.01.008. Epub 2012 Apr 26. Hum Pathol. 2012. PMID: 22542126
-
Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.Pathol Res Pract. 2019 Jun;215(6):152413. doi: 10.1016/j.prp.2019.04.005. Epub 2019 Apr 6. Pathol Res Pract. 2019. PMID: 30987832
-
[Revisions in the WHO histological classification of urothelial bladder tumors and flat urothelial lesions].Pathologe. 2000 May;21(3):211-7. doi: 10.1007/s002920050390. Pathologe. 2000. PMID: 10900613 Review. German.
-
Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.Am J Clin Pathol. 2010 May;133(5):788-95. doi: 10.1309/AJCP12MRVVHTCKEJ. Am J Clin Pathol. 2010. PMID: 20395527
-
What's new in WHO fifth edition - urinary tract.Histopathology. 2022 Oct;81(4):439-446. doi: 10.1111/his.14764. Epub 2022 Aug 16. Histopathology. 2022. PMID: 35942645 Review.
Cited by
-
Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.Am J Clin Pathol. 2025 Apr 19;163(4):618-628. doi: 10.1093/ajcp/aqae161. Am J Clin Pathol. 2025. PMID: 39705501
-
The Current Role of Contrast-Enhanced Ultrasound (CEUS) in the Diagnosis and Staging of Bladder Cancer: A Review of the Available Literature.Life (Basel). 2024 Jul 9;14(7):857. doi: 10.3390/life14070857. Life (Basel). 2024. PMID: 39063611 Free PMC article. Review.
-
Frequency and Characterization of Rare Histologic Subtypes in Canine Invasive Urothelial Carcinoma.bioRxiv [Preprint]. 2025 May 14:2025.05.13.651218. doi: 10.1101/2025.05.13.651218. bioRxiv. 2025. PMID: 40463261 Free PMC article. Preprint.
-
Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?Oncol Res. 2025 May 29;33(6):1377-1382. doi: 10.32604/or.2025.055306. eCollection 2025. Oncol Res. 2025. PMID: 40486882 Free PMC article.
-
Optimizing enfortumab vedotin plus pembrolizumab therapy.Oncotarget. 2025 Jun 17;16:481-494. doi: 10.18632/oncotarget.28741. Oncotarget. 2025. PMID: 40526099 Free PMC article. Review.
References
-
- Epstein JI, Amin MB, Reuter VR, et al. . The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-1448. https://doi.org/10.1097/00000478-199812000-00001. PMID: 9850170. 10.1097/00000478-199812000-00001 - DOI - PubMed
-
- Eble JN, Sauter G, Epstein J, et al.., editors. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon (France): IARC Press; 2004. (WHO classification of tumours series, 3rd ed.; vol. 7). https://publications.iarc.fr/7.
-
- Moch H, Humphrey PA, Ulbright TM, et al.., eds. WHO classification of tumours of the urinary system and male genital organs. Lyon (France): IARC Press; 2016. (WHO classification of tumours series, 4th ed.; vol. 8). https://publications.iarc.fr/540. - PubMed
-
- WHO Classification of Tumours Editorial Board. Urinary and male genital tumours. Lyon (France): IARC Press; 2022. (WHO classification of tumours series, 5th ed.; vol. 8).
-
- The Paris System (TPS) for reporting cytology. Rosenthal DL, Wojcik EM, Kurtycz DFI, editors. The Paris System for reporting urinary cytology. Cham (Switzerland): Springer International Publishing; 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical